Currently, Mikhail Blagosklonny is a professor of Oncology at Roswell Park Cancer Institute. Cancer has been seen to be the leading cause of death in all continents. This concept has attracted scientists from all walks of life to try and solve this problem by finding a cancer elusive treatment. As a scientist of Oncology, Mikhail Blagosklonny studies Cancer and Aging as he attempts to find a treatment for these two concepts. He has made numerous contributions towards finding an elusive treatment considering he is a specialist in treatment therapies and cancer biology. With his extensive research and academic background, Mikhail contributions in fighting cancer have some potential of being perfected to bring about cancer and aging treatment.
Career and Education Preview
Mr. Blagosklonny had the opportunity of studying at First Pavlov State Medical University based in St. Petersburg, Russia where he earned his MD in Internal Medicine and a Ph.D. in Cardiology and Experimental Medicine. With the help of his academic credentials, it was not hard for him to begin his career journey. In 2002, he joined the New York Medical College, Valhalla, New York as an associate professor. He later joined Ordway Research Institute as a research scientist. He continued to work in the firm as he wanted to gain the required experience. In 2009, he now joined Roswell Park Center to be a professor of Oncology a job he loves very much. He has been an excellent professor considering his experiences gained from working in different institutions. Some of his research interests include anti-aging and anticancer drugs, Biogerontology and therapies that protect healthy cells from being damaged.
Visit ResearchGate.Net to keep up to date with Mikhail’s latest work.
Mikhail Blagosklonny is responsible for authoring more than a hundred articles on the subjects of aging and cancer. He has also co-authored various research reviews and book chapters on both molecular and cellular biology of cancer cells considering their apoptosis, autophagy, and cycle. From his works cited he proposes the use of rapamycin, with the help of TOR signaling, to help in prolonging cell life in the human body. This is achieved through delaying autophagy, inhibiting apoptosis and promoting protein synthesis. He continues to argue that with the help of the TOR signaling regulation, cancer can be treated.
According to him, he believes it is possible to control aging and cancer, and he will one day be in a position of doing so. Check his LinkedIn profile to learn more.